NCT01776099

Brief Summary

In animal models and retrospective studies, certain food components such as sugars and fiber have been detected as potential agents to influence development and progress of type 2 diabetes. The DiNA study prospectively investigates, if non-soluble non-fermentable fibers (vs. soluble ones) and galactose (vs. palatinose) are capable to improvement metabolic parameters in patients with long-term type 2 diabetes and intensive insulin treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes

Timeline
Completed

Started Nov 2012

Longer than P75 for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 23, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 25, 2013

Completed
8.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

June 24, 2020

Status Verified

June 1, 2020

Enrollment Period

8.9 years

First QC Date

January 23, 2013

Last Update Submit

June 23, 2020

Conditions

Keywords

type 2 diabetesnutritionfibers

Outcome Measures

Primary Outcomes (1)

  • metabolic improvement of type 2 diabetes

    metabolic improvement of type 2 diabetes, as to be shown via hyperinsulinemic-euglycaemic clamp, mixed-meal test and daily demand of insulin units

    4 weeks

Study Arms (4)

pure galactose

ACTIVE COMPARATOR

5 grams of galactose, three times a day with the main meals, duration: 4 weeks

Dietary Supplement: Dietary supplement (4 arms, 2 active, 2 placebo)

pure palatinose

PLACEBO COMPARATOR

5 grams of palatinose, three times a day with the main meals, duration: 4 weeks

Dietary Supplement: Dietary supplement (4 arms, 2 active, 2 placebo)

soluble non-fermentable fibers

PLACEBO COMPARATOR

5 grams of soluble non-fermentable fibers, three times a day with the main meals, duration: 4 weeks

Dietary Supplement: Dietary supplement (4 arms, 2 active, 2 placebo)

non-soluble non-fermentable fibers

ACTIVE COMPARATOR

5 grams of non-soluble non-fermentable fibers, three times a day with each main meal, duration: 4 weeks

Dietary Supplement: Dietary supplement (4 arms, 2 active, 2 placebo)

Interventions

non-soluble non-fermentable fiberspure galactosepure palatinosesoluble non-fermentable fibers

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • type 2 diabetes, insulin-dependent
  • high insulin resistance

You may not qualify if:

  • accompanying disease, medication or metabolic disorder, which interact with glucose metabolism or eating behavior (e.g. renal insufficiency, major cardial insuffiency, untreated hypothyreosis, corticoid treatment, depression and other psychiatric disorders...)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charité-Klinikum Benjamin Franklin

Berlin, 12203, Germany

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Dietary Supplements

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Andreas F.H. Pfeiffer, Prof. Dr. med.

    German Institute for Human Nutrition

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the Department for Clinical Nutrition

Study Record Dates

First Submitted

January 23, 2013

First Posted

January 25, 2013

Study Start

November 1, 2012

Primary Completion

October 1, 2021

Study Completion

December 1, 2021

Last Updated

June 24, 2020

Record last verified: 2020-06

Locations